Samsara BioCapital portfolio
42 tracked investments, 7 on the map, $2.9B raised across the mapped portfolio.
Samsara BioCapital42 investments · 7 on the map · $2.9B raised- Janux TherapeuticsSeries B
- Scholar RockPost-IPO Equity
- Mineralys TherapeuticsPost-IPO Equity
- LENZ THERAPEUTICS
- Spyglass Pharma
- Genalyte
- ElevateBioSeries D
Also in the portfolio
- Ambrosia Biosciences
- Sidewinder Therapeutics
- Seismic Therapeutic
- CARGO Therapeutics
- Excellergy
- EpiBiologics
- Elektrofi
- Normunity
- Enara Bio
- Enlaza Therapeutics
- Dewpoint Therapeutics
- Upstream Bio
- Synthekine
- Tentarix Biotherapeutics
- Abcuro
- Abata Therapeutics
- Alpheus Medical
- ACELYRIN
- Simcha Therapeutics
- Eyebiotech
- Notch Therapeutics
- Exo Therapeutics
- Inventiva Pharma
- Lyra Therapeutics
- Rain Oncology
- Kalaris Therapeutics (formerly AlloVir)
- Atreca
- FORMA Therapeutics
- vTv Therapeutics
- Chinook Therapeutics
- Neurogastrx
- Hookipa Pharma
- Pieris Pharmaceuticals
- Autobahn Labs
Investors similar to Samsara BioCapital
RA Capital Management150 investments · 92 on the map · $6.7B raised
OrbiMed177 investments · 137 on the map · $9.6B raised
Invus86 investments · 16 on the map · $3.7B raised
Redmile Group61 investments · 14 on the map · $5.4B raised
HBM Healthcare Investments56 investments · 10 on the map · $3.4B raised
New Enterprise Associates542 investments · 411 on the map · $13.4B raised